Potent, non-competitive antagonis of NMDA receptort (IC50 = 93 nM) that inhibits inward currents evoked by NMDA in central nervous system neurons (IC50 = 350 nM). Exhibits broad anticonvulsant and antiparkinsonian activity in vivo at doses devoid of behavioral toxicity.
Conantokin-R is a unique peptide compound originally isolated from the venom of the marine cone snail species *Conus radiatus*. Structurally characterized by its γ-carboxyglutamate (Gla) residues, this peptide belongs to the conantokin family, which is renowned for modulating ion channel activity, particularly N-methyl-D-aspartate (NMDA) receptors. Its distinctive sequence and post-translational modifications confer specialized properties that make Conantokin-R a valuable tool in neurobiological and biochemical research. The compound's ability to interact with specific subtypes of NMDA receptors has positioned it as a model system for studying peptide-receptor interactions, synaptic modulation, and the broader landscape of neuroactive venom peptides.
Neuropharmacological research: As a selective modulator of NMDA-type glutamate receptors, Conantokin-R is widely used in neuropharmacological studies to elucidate the functional roles of these receptors in synaptic transmission and plasticity. Its specificity for certain NMDA receptor subunits enables researchers to dissect the molecular basis of excitatory neurotransmission and to investigate the mechanisms underlying synaptic modulation, excitotoxicity, and neuroprotection. By providing a means to selectively perturb NMDA receptor function, the peptide supports the development of new hypotheses regarding neuronal signaling and receptor pharmacology.
Ion channel functional studies: The unique structure of Conantokin-R, particularly its Gla residues, enables it to interact with and modulate ion channel activity in a calcium-dependent manner. This property makes the peptide a valuable probe for studying the biophysical characteristics of ligand-gated ion channels and the influence of post-translational modifications on peptide-channel interactions. Researchers utilize it to map binding sites, assess channel gating mechanisms, and explore the structural determinants of peptide-mediated channel modulation in both native and recombinant systems.
Peptide engineering and structure-activity relationship (SAR) analysis: The sequence and functional diversity of conantokins, including Conantokin-R, provide a robust framework for peptide engineering and SAR studies. By serving as a template for site-directed mutagenesis and synthetic modification, the compound helps elucidate the relationship between sequence, structure, and function in bioactive peptides. These investigations yield insights into the design of novel peptide analogs with tailored receptor selectivity, improved stability, or altered pharmacodynamic profiles, advancing both basic science and applied peptide research.
Venom peptide discovery and evolutionary studies: As a representative of conopeptides, Conantokin-R is integral to research focused on the molecular evolution and diversification of venom-derived peptides. Its characterization aids in understanding the evolutionary pressures shaping peptide toxins and their functional adaptation to specific molecular targets. Comparative studies utilizing this peptide contribute to the annotation of conotoxin gene families, the identification of novel bioactive sequences, and the elucidation of the evolutionary mechanisms underlying venom complexity.
Analytical method development: The physicochemical properties and distinctive post-translational modifications of Conantokin-R make it an ideal standard or reference material for the development and validation of analytical techniques. Its use in mass spectrometry, high-performance liquid chromatography (HPLC), and related methods enables accurate detection, quantification, and characterization of Gla-containing peptides. By facilitating method optimization and ensuring analytical reliability, the compound supports a wide array of peptide-centric research and quality control applications.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More